Lucid Diligence Brief: Incyte and Genesis Expand Molecular AI Collaboration to Accelerate Drug Discovery
Lucid Diligence Brief: Incyte and Genesis Molecular AI expand collaboration…
Lucid Diligence Brief: Cullinan Therapeutics Gains FDA Orphan Drug Designation for CLN-049
Lucid Diligence Brief: Cullinan Therapeutics Receives FDA Orphan Drug…
Lucid Diligence Brief: Plus Therapeutics and Ephemeral AI Partnership in CNS Oncology
Lucid Diligence Brief: Plus Therapeutics and Ephemeral AI partnership raises…
Lucid Diligence Brief: Endologix's Pounce Acquisition
Lucid Diligence Brief: Endologix’s Pounce acquisition framed through clinical,…
Lucid Diligence Brief: Helio Genomics and Syneos Health Deal
Lucid Diligence Brief: Helio Genomics and Syneos Health Deal to expand…
Lucid Diligence Brief: Regeneron collaboration with Parabilis Medicines
Lucid Diligence Brief: Regeneron collaboration with Parabilis Medicines…
Lucid Diligence Brief: Iterative Health Acquisition of NextStage Cardiology Research Sites
Lucid Diligence Brief: Iterative Health Acquisition of NextStage Cardiology…
Lucid Diligence Brief: ERS Genomics and Aurigene CRISPR/Cas9 License
Lucid Diligence Brief: ERS Genomics’ CRISPR/Cas9 IP license to Aurigene raises…
Lucid Diligence Brief: Catalent and Elpida Therapeutics announced a strategic partnership for late-phase AAV manufacturing
Lucid Diligence Brief: Catalent and Elpida Therapeutics announced a strategic…
Lucid Diligence Brief: Glooko and mylife Diabetes Care expand diabetes data partnership
Lucid Diligence Brief: Glooko and mylife Diabetes Care expand diabetes data…
Lucid Diligence Brief: NeuroVision’s Durin Life Sciences acquisition
Lucid Diligence Brief: NeuroVision’s Durin Life Sciences acquisition…
Lucid Diligence Brief: Basata $21 million Series A
Lucid Diligence Brief: Basata $21 million Series A Professional audiences only.…